AMEERA-5: a randomized, double-blind phase 3 study of amcenestrant plus palbociclib versus letrozole plus palbociclib for previously untreated ER+/HER2– advanced breast cancer
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359221083956
Abstract: Background: For estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC), the current standard first-line treatment includes an aromatase inhibitor in combination with a cyclin-dependent kinase 4/6 inhibitor. When resistance occurs,… read more here.
Keywords: breast cancer; letrozole plus; her2; plus palbociclib ... See more keywords
Comparison of the Effect of Letrozole Alone With Letrozole Plus N-Acetylcysteine on Pregnancy Rate in Patients With Polycystic Ovarian Syndrome: A Randomized Clinical Trial
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Women's Health"
DOI: 10.15296/ijwhr.2021.13
Abstract: Objectives: Different drugs are prescribed for the induction of ovulation in patients with polycystic ovary syndrome (PCOS). The aim of this study was to compare the effect of letrozole alone with letrozole plus N-acetyl cysteine… read more here.
Keywords: letrozole plus; patients polycystic; pregnancy rate; rate ... See more keywords